Diagnosis Treatment Awareness Symptoms Illness Research Risk Factors Stage 4 Cancer Health Challenges Impact on Life
The discovery points to using CD44 or EPHA2 as delivery targets together with short, controlled inhibition of cellular repair to raise ASO potency.